FKBP5 methylation as a possible marker for cortisol state and transient cortisol exposure in healthy human subjects

Epigenomics. 2017 Oct;9(10):1279-1286. doi: 10.2217/epi-2017-0057. Epub 2017 Sep 6.

Abstract

Current glucocorticoid replacement regimens, in adrenal insufficiency, fail to mimic the physiological cortisol secretion, thereby fostering serious side effects.

Aim: To experimentally evaluate the impact of CpG methylation within the FKBP5 gene as a possible short- and long-term marker for cortisol exposure in humans.

Materials & methods: An ACTH-stimulation test was carried out and methylation status of the FKBP5 gene in leukocytes was determined.

Results: A negative correlation between basal levels of methylation and serum cortisol was observed. Individual changes in FKBP5 methylation after 24 h correlated with cortisol responses.

Conclusion: Considering previous studies conducted with murine leucocytes, FKBP5 methylation may be suitable as a long-term biomarker, rather than acute glucocorticoid exposure, also in humans.

Keywords: ACTH stimulation test; FKBP5; demethylation; glucocorticoid exposure; hydrocortisone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • CpG Islands
  • DNA Methylation*
  • Female
  • Humans
  • Hydrocortisone / blood*
  • Hydrocortisone / genetics
  • Male
  • Tacrolimus Binding Proteins / genetics*

Substances

  • Biomarkers
  • Tacrolimus Binding Proteins
  • tacrolimus binding protein 5
  • Hydrocortisone